-
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Dual GLP-1/GIP Receptor Agonist BGM0504Product Name: Dual GLP-1/GIP receptor agonist BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Semaglutide Oral Tablets 7mgProduct Name: Semaglutide Oral Tablet 7mg Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Argatroban InjectionProduct Name: Argatroban Injection Cas. 74863-84-6 Molecular Formula C23H36N6O5S Molecular Weight 508.63 Appearance White to off-white powderread more
-
Fondaparinux Sodium InjectionProduct Name: Fondaparinux Sodium Injection Cas. 114870-03-0 Molecular Formula C31H43N3Na10O49S8 Molecular Weight 1728.08 Appearance Colorless liquidread more
-
Tiotropium Bromide SMIProduct Name: Tiotropium Bromide Cas. 136310-93-5 Molecular Formula C19H22BrNO4S2 Molecular Weight 472.42 Appearance White or off-white powderread more
-
Tiotropium Bromide and Olodaterol Hydrochloride SMIProduct Name: Tiotropium Bromide and Olodaterol Hydrochloride Appearance Colorless liquidread more
-
Octreotide Acetate LAR InjectionProduct Name: Octreotide Acetate LAR Injection Cas. 83150-76-9 Molecular Formula C49H66N10O10S2 Molecular Weight 1019.24 Appearance Colorless liquidread more
-
Minocycline Hydrochloride LAR InjectionProduct Name: Minocycline Hydrochloride LAR Injection Cas. 13614-98-7 Molecular Formula C23H28ClN3O7 Molecular Weight 493.94 Appearance Yellow crystalline powderread more
-
Triptorelin Pamoate LAR InjectionProduct Name: Triptorelin Pamoate LAR Injection Cas. 57773-63-4 Molecular Formula C64H82N18O13 Molecular Weight 1311.45 Appearance White to off-white powderread more
-
Leuprorelin Acetate LAR InjectionProduct Name: Leuprorelin Acetate LAR Injection Cas. 74381-53-6 Molecular Formula C61H88N16O14 Molecular Weight 1269.47 Appearance White to off-white powderread more
Feb 20, 2024 — Notably, domestic innovation is flourishing, with five first-in-class drugs, including Glumetinib, a c-Met inhibitor from Haihe Biopharma; Leritrelvir, a 3CL protease inhibitor from...
Jan 4, 2024 — 2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, weight loss, and the first treatment based on the gene-editing technology CRISPR....
Nov 10, 2021 — This article analyses the timeframes of successful drug development programmes from 2010 to 2020, based on US FDA review documents. It also investigates how FDA regulatory programmes...
Innovative drugs often mean new treatment options for patients and advances in health care for the American public. When it comes the development of new drugs and therapeutic biological......
Jun 24, 2023 — In the development of an optimal drug delivery system, recent drug delivery systems are recognized to be the newest developments and innovative understanding of the...
Jul 5, 2023 — Biotech companies were the most important origin of innovation (47% of new drugs) for the top 20 companies. In addition, the internal R&D of the top 20 companies overall has had a...
